Safety of Ceasing Aspirin Used Without a Clinical Indication After Age 70 Years: A Subgroup Analysis of the ASPREE Randomized Trial.
作者信息
Nelson Mark R, Polekhina Galina, Woods Robyn L, Reid Christopher M, Tonkin Andrew M, Wolfe Rory, Murray Anne M, Kirpach Brenda, Ernst Michael E, Lockery Jessica E, Shah Raj C, Stocks Nigel, Orchard Suzanne G, Zhou Zhen
机构信息
Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, and School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
出版信息
Ann Intern Med. 2022 May;175(5):761-764. doi: 10.7326/M21-3823. Epub 2022 Mar 15.
Abstract
摘要
相似文献
1
Safety of Ceasing Aspirin Used Without a Clinical Indication After Age 70 Years: A Subgroup Analysis of the ASPREE Randomized Trial.70岁后停用无临床指征使用的阿司匹林的安全性：ASPREE随机试验的亚组分析
Ann Intern Med. 2022 May;175(5):761-764. doi: 10.7326/M21-3823. Epub 2022 Mar 15.
2
Genetic Variation in PEAR1, Cardiovascular Outcomes and Effects of Aspirin in a Healthy Elderly Population.PEAR1 基因变异与心血管结局及健康老年人群阿司匹林效应的关系
Clin Pharmacol Ther. 2020 Dec;108(6):1289-1298. doi: 10.1002/cpt.1959. Epub 2020 Jul 20.
3
Rationale for a trial of low-dose aspirin for the primary prevention of major adverse cardiovascular events and vascular dementia in the elderly: Aspirin in Reducing Events in the Elderly (ASPREE).低剂量阿司匹林用于老年人主要不良心血管事件和血管性痴呆一级预防试验的原理：阿司匹林降低老年人事件风险（ASPREE）。
Drugs Aging. 2003;20(12):897-903. doi: 10.2165/00002512-200320120-00004.
4
Harms and Benefits of Using Aspirin for Primary Prevention of Cardiovascular Disease: A Narrative Overview.阿司匹林用于心血管疾病一级预防的危害与获益：叙述性综述。
Semin Thromb Hemost. 2019 Mar;45(2):157-163. doi: 10.1055/s-0038-1675380. Epub 2018 Oct 22.
5
Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly.阿司匹林对健康老年人心血管事件和出血的影响。
N Engl J Med. 2018 Oct 18;379(16):1509-1518. doi: 10.1056/NEJMoa1805819. Epub 2018 Sep 16.
6
The role of aspirin as antiaggregant therapy in primary prevention. An update.阿司匹林作为初级预防中的抗血小板治疗作用。最新进展。
Med Clin (Barc). 2019 Oct 25;153(8):326-331. doi: 10.1016/j.medcli.2019.05.024. Epub 2019 Sep 11.
7
A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.低剂量阿司匹林用于女性心血管疾病一级预防的随机试验。
N Engl J Med. 2005 Mar 31;352(13):1293-304. doi: 10.1056/NEJMoa050613. Epub 2005 Mar 7.
8
Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin.基于接受利伐沙班或阿司匹林的患者的大型多年随机试验的质子泵抑制剂安全性。
Gastroenterology. 2019 Sep;157(3):682-691.e2. doi: 10.1053/j.gastro.2019.05.056. Epub 2019 May 29.
9
[Safety of reintroducing platelet-inhibitory doses of aspirin in patients with urticaria or angioedema induced by anti-inflammatory doses].[重新给予抗炎剂量引发的荨麻疹或血管性水肿患者血小板抑制剂量阿司匹林的安全性]
Ann Dermatol Venereol. 2009 Jan;136(1):15-20. doi: 10.1016/j.annder.2008.10.022. Epub 2008 Dec 18.
10
Rationale and design of a randomized, double-blind, parallel-group study of terutroban 30 mg/day versus aspirin 100 mg/day in stroke patients: the prevention of cerebrovascular and cardiovascular events of ischemic origin with terutroban in patients with a history of ischemic stroke or transient ischemic attack (PERFORM) study.一项关于替罗非班30毫克/天与阿司匹林100毫克/天治疗中风患者的随机、双盲、平行组研究的原理与设计：替罗非班预防有缺血性中风或短暂性脑缺血发作病史患者的缺血性脑血管和心血管事件（PERFORM）研究
Cerebrovasc Dis. 2009;27(5):509-18. doi: 10.1159/000212671. Epub 2009 Apr 16.
引用本文的文献
1
Short- and long-term impact of aspirin cessation in older adults: a target trial emulation.老年人停用阿司匹林的短期和长期影响：一项目标试验模拟。
BMC Med. 2024 Jul 29;22(1):306. doi: 10.1186/s12916-024-03507-8.
2
Outcomes After Aspirin Discontinuation Among Baseline Users in Contemporary Primary Prevention Aspirin Trials: A Meta-Analysis.当代初级预防阿司匹林试验中基线使用者停用阿司匹林后的结局：一项荟萃分析。
Circulation. 2024 Feb 27;149(9):722-724. doi: 10.1161/CIRCULATIONAHA.123.065420. Epub 2024 Feb 26.
3
Pantoprazole and Vonoprazan Performed Well in Preventing Peptic Ulcer Recurrence in Low-Dose Aspirin Users.泮托拉唑和沃诺拉赞在预防低剂量阿司匹林使用者消化性溃疡复发方面表现良好。
Dig Dis Sci. 2024 Mar;69(3):670-682. doi: 10.1007/s10620-023-08233-4. Epub 2024 Jan 22.
4
Trends in Upper Gastrointestinal Bleeding in Patients on Primary Prevention Aspirin: A Nationwide Emergency Department Sample Analysis, 2016-2020.2016-2020 年全国急诊样本分析：初级预防阿司匹林治疗患者上消化道出血趋势。
Am J Med. 2023 Dec;136(12):1179-1186.e1. doi: 10.1016/j.amjmed.2023.08.010. Epub 2023 Sep 9.
本文引用的文献
1
"Doctor, Should I Keep Taking an Aspirin a Day?".医生，我应该继续每天服用一片阿司匹林吗？
N Engl J Med. 2019 May 16;380(20):1967-1970. doi: 10.1056/NEJMclde1903004.
2
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.2019美国心脏病学会/美国心脏协会心血管疾病一级预防指南：美国心脏病学会/美国心脏协会临床实践指南工作组报告
Circulation. 2019 Sep 10;140(11):e596-e646. doi: 10.1161/CIR.0000000000000678. Epub 2019 Mar 17.
3
Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly.阿司匹林对健康老年人心血管事件和出血的影响。
N Engl J Med. 2018 Oct 18;379(16):1509-1518. doi: 10.1056/NEJMoa1805819. Epub 2018 Sep 16.
4
Effect of Aspirin on Disability-free Survival in the Healthy Elderly.阿司匹林对健康老年人无残疾生存的影响。
N Engl J Med. 2018 Oct 18;379(16):1499-1508. doi: 10.1056/NEJMoa1800722. Epub 2018 Sep 16.
5
Effect of Aspirin on All-Cause Mortality in the Healthy Elderly.阿司匹林对健康老年人全因死亡率的影响。
N Engl J Med. 2018 Oct 18;379(16):1519-1528. doi: 10.1056/NEJMoa1803955. Epub 2018 Sep 16.
Zotero 插件